BIA and RNID Webinar: Preparing for clinical trials in a novel therapeutic area

Completing a practical and meaningful clinical trial is essential to delivering on the promise of a new therapeutic. However, it can be a real challenge to do this, particularly for an emerging therapeutic area, where existing trial infrastructure may be limited.

As you may have seen remarkable progress is being made in the emerging therapeutic area of hearing loss  with gene therapies showing real promise in phase 1/2 trials. 

In this webinar, panel members will share case studies of their experiences in novel hearing loss clinical trials, in order to help companies working in other emerging areas think about the obstacles and opportunities that exist in setting up and executing your trial, and what you can do to ensure it is as effective as possible.

Alex Churchill

Alex Churchill

Deputy Director, Head of Commercial Clinical Trials, Department of Health and Social Care

Mehul Patel

Mehul Patel

VP of Respiratory Clinical Development, AstraZeneca

Anne Schilder

Anne Schilder

Director, evidENT UCL Ear Institute

Vassili Valayannopoulos

Vassili Valayannopoulos

VP & Head of Clinical Research and Development, Decibel Therapeutics

 

Register